Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

SPRY holding history

ARS Pharmaceuticals, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SPRY overviewAll 13F holders of SPRYFull Q2 2026 holdings

Shares (Q2 2026)
1,939,654
Value
$15.5M
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of SPRY by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,939,654$15.5M<0.1%−320,671−14.2%ReducedHolders
Q1 20262,260,325$18.2M<0.1%+49,459+2.2%AddedHolders
Q4 20252,210,866$25.8M<0.1%+1,550,980+235.0%AddedHolders
Q3 2025659,886$6.63M<0.1%−207,049−23.9%ReducedHolders
Q2 2025866,935$15.1M<0.1%+275,753+46.6%AddedHolders
Q1 2025591,182$7.44M<0.1%−421,519−41.6%ReducedHolders
Q4 20241,012,701$10.7M<0.1%+902,819+821.6%AddedHolders
Q3 2024109,882$1.59M<0.1%+44,960+69.3%AddedHolders
Q2 202464,922$552.5K<0.1%−39,519−37.8%ReducedHolders
Q1 2024104,441$1.07M<0.1%+102,713+5,944.0%AddedHolders
Q4 20231,728$9.47K<0.1%+1,728NewHolders
Q2 20230$00.0%−2,903−100.0%Sold outHolders
Q1 20232,903$18.9K<0.1%+2,903NewHolders
Q4 20220$00.0%−12−100.0%Sold outHolders
Q3 202212$00.0%−490−97.6%ReducedHolders
Q2 2022502$2.00K<0.1%−11−2.1%ReducedHolders
Q1 2022513$2.00K<0.1%−78,327−99.3%ReducedHolders
Q4 202178,840$525.0K<0.1%+65,110+474.2%AddedHolders
Q3 202113,730$137.0K<0.1%+13,555+7,745.7%AddedHolders
Q2 2021175$5.00K<0.1%−3,364−95.1%ReducedHolders
Q1 20213,539$154.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.